NASDAQ · GALT

Galectin Therapeutics Inc

Closing price · Nov 13, 2026 $3.05
Last insider buy price $2.70 Paid by Director Kary Eldred on Feb 6, 2026 (Form 4). Not today's price.

Latest quarter · ended Jun 30, 2026

Cash got weaker

descriptionFiled Aug 14, 2026
Cash from operationsBetter
−$2.44M
Quarter ended Sep 30, 2024: −$8.54M cash from operationsQuarter ended Dec 31, 2024: −$12.8M cash from operationsQuarter ended Mar 31, 2025: −$7.69M cash from operationsQuarter ended Jun 30, 2025: −$6.6M cash from operationsQuarter ended Sep 30, 2025: −$3.54M cash from operationsQuarter ended Dec 31, 2025: −$6.04M cash from operationsQuarter ended Mar 31, 2026: −$3.87M cash from operationsQuarter ended Jun 30, 2026: −$2.44M cash from operations
Sep '24Jun '26
vs. −$6.6M a year ago
Share countDiluting
+57.4%
Quarter ended Sep 30, 2024: 62.76M sharesQuarter ended Dec 31, 2024: 63.18M sharesQuarter ended Mar 31, 2025: 63.29M sharesQuarter ended Jun 30, 2025: 64.06M sharesQuarter ended Sep 30, 2025: 64.47M sharesQuarter ended Dec 31, 2025: 65.83M sharesQuarter ended Mar 31, 2026: 65.86M sharesQuarter ended Jun 30, 2026: 100.85M shares
Sep '24Jun '26
100.85M shares vs. 64.06M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

100 funds report owning GALT, up from 98

Holdings as of Jun 30, 2026
New22
Added24
Held32
Trimmed22
Sold out20

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOption exercise · Dec 8 · $321KPlanned sale (10b5-1) · Dec 8 · $831KOption exercise · Dec 9 · $69.8KPlanned sale (10b5-1) · Dec 9 · $105KOption exercise · Dec 12 · $82.3KPlanned sale (10b5-1) · Dec 12 · $124KOption exercise · Dec 15 · $35KPlanned sale (10b5-1) · Dec 15 · $53KPlanned sale (10b5-1) · Dec 17 · $137KOption exercise · Dec 17 · $35.5KOption exercise · Dec 17 · $22.4KPlanned sale (10b5-1) · Dec 17 · $55.3KPlanned sale (10b5-1) · Dec 17 · $172KOption exercise · Dec 17 · $39.6KPlanned sale (10b5-1) · Dec 31 · $33.1KOption exercise · Dec 31 · $9.99KOption exercise · Jan 2 · 60,000 shPlanned sale (10b5-1) · Jan 2 · $58.4KOption exercise · Jan 2 · 60,000 shPlanned sale (10b5-1) · Jan 2 · $54.8KPlanned sale (10b5-1) · Jan 2 · $78KOption exercise · Jan 2 · 84,000 shPlanned sale (10b5-1) · Jan 5 · $100KPlanned sale (10b5-1) · Jan 5 · $99.4KPlanned sale (10b5-1) · Jan 5 · $108KCode · Jan 5 · $219KPlanned sale (10b5-1) · Jan 6 · $74.7KPlanned sale (10b5-1) · Jan 6 · $78.3KPlanned sale (10b5-1) · Jan 6 · $135KStock grant · Jan 16 · $40KPlanned sale (10b5-1) · May 26 · $1.76KOption exercise · May 26 · $699Option exercise · Jun 23 · $9.3KPlanned sale (10b5-1) · Jun 23 · $23.7KOption exercise · Jun 26 · $10.8KPlanned sale (10b5-1) · Jun 26 · $22.9KOption exercise · Jun 26 · $9.51KPlanned sale (10b5-1) · Jun 26 · $38.7KOption exercise · Jun 29 · $119KPlanned sale (10b5-1) · Jun 29 · $239KOption exercise · Jun 29 · $27.4KPlanned sale (10b5-1) · Jun 29 · $112KOption exercise · Jul 14 · $49.4KPlanned sale (10b5-1) · Jul 14 · $83.4KOption exercise · Jul 31 · $106MOpen-market buy · Dec 23 · $22.1K · 2 peopleOpen-market buy · Feb 6 · $810
CEOCFOOther officersDirectorsDecFebAprJunAugOctOption exercise · Dec 8 · $321KPlanned sale (10b5-1) · Dec 8 · $831KOption exercise · Dec 9 · $69.8KPlanned sale (10b5-1) · Dec 9 · $105KOption exercise · Dec 12 · $82.3KPlanned sale (10b5-1) · Dec 12 · $124KOption exercise · Dec 15 · $35KPlanned sale (10b5-1) · Dec 15 · $53KPlanned sale (10b5-1) · Dec 17 · $137KOption exercise · Dec 17 · $35.5KOption exercise · Dec 17 · $22.4KPlanned sale (10b5-1) · Dec 17 · $55.3KPlanned sale (10b5-1) · Dec 17 · $172KOption exercise · Dec 17 · $39.6KPlanned sale (10b5-1) · Dec 31 · $33.1KOption exercise · Dec 31 · $9.99KOption exercise · Jan 2 · 60,000 shPlanned sale (10b5-1) · Jan 2 · $58.4KOption exercise · Jan 2 · 60,000 shPlanned sale (10b5-1) · Jan 2 · $54.8KPlanned sale (10b5-1) · Jan 2 · $78KOption exercise · Jan 2 · 84,000 shPlanned sale (10b5-1) · Jan 5 · $100KPlanned sale (10b5-1) · Jan 5 · $99.4KPlanned sale (10b5-1) · Jan 5 · $108KCode · Jan 5 · $219KPlanned sale (10b5-1) · Jan 6 · $74.7KPlanned sale (10b5-1) · Jan 6 · $78.3KPlanned sale (10b5-1) · Jan 6 · $135KStock grant · Jan 16 · $40KPlanned sale (10b5-1) · May 26 · $1.76KOption exercise · May 26 · $699Option exercise · Jun 23 · $9.3KPlanned sale (10b5-1) · Jun 23 · $23.7KOption exercise · Jun 26 · $10.8KPlanned sale (10b5-1) · Jun 26 · $22.9KOption exercise · Jun 26 · $9.51KPlanned sale (10b5-1) · Jun 26 · $38.7KOption exercise · Jun 29 · $119KPlanned sale (10b5-1) · Jun 29 · $239KOption exercise · Jun 29 · $27.4KPlanned sale (10b5-1) · Jun 29 · $112KOption exercise · Jul 14 · $49.4KPlanned sale (10b5-1) · Jul 14 · $83.4KOption exercise · Jul 31 · $106MOpen-market buy · Dec 23 · $22.1K · 2 peopleOpen-market buy · Feb 6 · $810

Last 12 months. No real trades in the last 6.

Showing 3 real trades. Hidden: 1 stock grant, 19 option exercises, 24 planned 10b5-1 sales. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Feb 6 Kary Eldred Past buys: 4 of 5 beat Director Open-market buy $810 300 sh at $2.70
Dec 23 Kevin Freeman Past buys: 2 of 4 beat Director Open-market buy $19.5K 5,500 sh at $3.55
Dec 23 Kary Eldred Past buys: 4 of 5 beat Director Open-market buy $2.61K 700 sh at $3.73

"Past buys: 2 of 3 beat" means this insider bought stock in 3 earlier quarters, and in 2 of them what they bought did better than the typical stock over the next 6 months. A past record is data, not a forecast.

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in GALT

As of Jun 30, 2026
FundOwnsValueChange
BlackRock, Inc.3.0%$13.9M+274%
Vanguard Capital Management LLC2.1%$10.1M+10%
Geode Capital Management, LLC1.3%$6.07M+114%
Osaic Holdings, Inc.1.2%$5.59M+7%
Marshall Wace, LLP0.8%$3.86M−32%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast